NASDAQ:LFST - LifeStance Health Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $33.40
  • Forecasted Upside: 48.64 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$22.47
▼ -0.17 (-0.75%)

This chart shows the closing price for LFST by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New LifeStance Health Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LFST and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LFST

Analyst Price Target is $33.40
▲ +48.64% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for LifeStance Health Group in the last 3 months. The average price target is $33.40, with a high forecast of $36.00 and a low forecast of $25.00. The average price target represents a 48.64% upside from the last price of $22.47.

This chart shows the closing price for LFST for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 investment analysts is to buy stock in LifeStance Health Group.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/6/2021UBS GroupInitiated CoverageBuy$34.00Medium
7/6/2021JPMorgan Chase & Co.Initiated CoverageOverweight$36.00Medium
7/6/2021William BlairInitiated CoverageOutperformMedium
7/6/2021Morgan StanleyInitiated CoverageOverweight$36.00Medium
7/5/2021The Goldman Sachs GroupInitiated CoverageNeutral$25.00Medium
7/5/2021Jefferies Financial GroupInitiated CoverageBuy$36.00Medium
(Data available from 7/23/2016 forward)
LifeStance Health Group logo
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Read More

Today's Range

Now: $22.47
Low: $21.89
High: $23.23

50 Day Range

MA: N/A

52 Week Range

Now: $22.47
Low: $19.55
High: $29.81

Volume

484,725 shs

Average Volume

886,384 shs

Market Capitalization

$8.40 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of LifeStance Health Group?

The following sell-side analysts have issued reports on LifeStance Health Group in the last twelve months: Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, The Goldman Sachs Group, Inc., UBS Group AG, and William Blair.
View the latest analyst ratings for LFST.

What is the current price target for LifeStance Health Group?

5 Wall Street analysts have set twelve-month price targets for LifeStance Health Group in the last year. Their average twelve-month price target is $33.40, suggesting a possible upside of 48.6%. JPMorgan Chase & Co. has the highest price target set, predicting LFST will reach $36.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $25.00 for LifeStance Health Group in the next year.
View the latest price targets for LFST.

What is the current consensus analyst rating for LifeStance Health Group?

LifeStance Health Group currently has 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LFST will outperform the market and that investors should add to their positions of LifeStance Health Group.
View the latest ratings for LFST.

What other companies compete with LifeStance Health Group?

How do I contact LifeStance Health Group's investor relations team?

The company's listed phone number is 425 279 8500. The official website for LifeStance Health Group is www.lifestance.com.